Julie is a dedicated resource for summer associates and associates who want to sharpen their legal writing skills. She works one-on-one with lawyers and teaches workshops that address common writing challenges. In Chambers Associate, our associates called Julie "an invaluable asset to the firm."
Women in Law Empowerment Forum awarded Schiff Hardin its 2015 Gold Standard in Recognition of Integration of Women in the Firm for the 3rd straight year. Schiff Hardin was one of only eight firms in the nation to earn a perfect score.
As detailed by Bloomberg BNA, partner Fred Sperling represented Michael Jordan in his successful $8.9M jury verdict in August 2015 and is representing Pelé IP Ownership regarding the unauthorized use of the Brazilian soccer legend’s identity.
Eddie Bolden spent 22 years in jail for a murder he did not commit. Associates Kristen Viglione and Kevin Whelan worked with pro bono counsel to obtain his release and change his life forever.
Human Rights Campaign Awards Perfect Score on 2016 Corporate Equality Index for Sixth Consecutive Year
Twenty-eight Schiff Hardin attorneys and eight practice areas receive leading rankings for 2015.
Schiff Hardin ranked #4 for Associate/Partner Relations, #7 for Firm Culture,and #8 for Transparency.
The environmental challenges facing businesses are growing. Businesses must navigate both the shifting sands of environmental rules and the relentless onslaught of toxic-tort and enforcement suits. We have experience in all of these areas. From negotiating with EPA and dozens of responsible parties at the Gowanus Canal in Brooklyn to defending a San Francisco utility against a challenge involving its utility poles, we work closely with clients, regulators, scientists, and engineers to find creative solutions to the increasingly complex challenges facing businesses today.
Patent litigation is in the spotlight as generic drug manufacturers try to bring their products to market—including biosimilars and biologics. With one of the premier Hatch-Waxman Litigation practices in the nation, and over 15 years of experience litigating pharma patents, we represent the world’s companies leading the push to make medicine more affordable for consumers.